Dr. Reddy's Laboratories Limited announced consolidated earnings results for the second quarter and half year ended September 30, 2018. For the quarter, the company reported revenues of INR 37,978 million against INR 35,460 million a year ago. Results from operating activities were INR 5,046 million against INR 3,808 million a year ago. Profit before tax was INR 5,780 million against INR 3,876 million a year ago. Profit after tax was INR 5.0 billion. Profit for the period was INR 5,038 million or INR 30.31 per diluted share against INR 2,849 million or INR 17.15 per diluted share a year ago. EBITDA was INR 8,646 million against INR 6,888 million a year ago.

For the half year, the company reported revenue of INR 75,190 million. Profit before tax was INR 10,790 million. Profit after tax was INR 9,600 million. Capital expenditure was INR 1.4 billion.

The company expects effective tax rate for the full year to be around 20%.

The company expects the performance in the second half of the fiscal year to improve on the back of new product launches and stabilization of supplies to the market.